{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:33:55Z","timestamp":1791855235455,"version":"4.3.4"},"reference-count":79,"publisher":"Archives of Endocrinology and Metabolism","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,30]]},"DOI":"10.20945\/2359-3997000000626","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T13:50:01Z","timestamp":1685541001000},"source":"Crossref","is-referenced-by-count":36,"title":["Hypophosphatasia: from birth to adulthood"],"prefix":"10.20945","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-9000","authenticated-orcid":false,"given":"Fernanda Salles","family":"Reis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-2834","authenticated-orcid":false,"given":"Marise","family":"Lazaretti-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20230531094941_B1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archpedi.1948.02030020840003","article-title":"Hypophosphatasia: a new developmental anomaly","volume":"75","author":"Rathbun","year":"1948","unstructured":"1 Rathbun JC. Hypophosphatasia: a new developmental anomaly. Am J Dis Child. 1948;75:822-31.","journal-title":"Am J Dis Child"},{"key":"key20230531094941_B2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-62703-562-0_3","article-title":"Multisystemic functions of alkaline phosphatases","volume":"1053","author":"Buchet","year":"2013","unstructured":"2 Buchet R, Mill\u00e1n JL, Magne D. Multisystemic functions of alkaline phosphatases. Methods Mol Biol. 2013;1053:27-51.","journal-title":"Methods Mol Biol"},{"issue":"24","key":"key20230531094941_B3","doi-asserted-by":"crossref","first-page":"12002","DOI":"10.1016\/S0021-9258(18)37885-2","article-title":"Structure of the human liver\/bone\/kidney alkaline phosphatase gene","volume":"263","author":"Weiss","year":"1988","unstructured":"3 Weiss MJ, Ray K, Henthorn PS, Lamb B, Kadesch T, Harris H. Structure of the human liver\/bone\/kidney alkaline phosphatase gene. J Biol Chem. 1988;263(24):12002-10.","journal-title":"J Biol Chem"},{"issue":"6","key":"key20230531094941_B4","first-page":"2142","article-title":"Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity","volume":"81","author":"Whyte","year":"1996","unstructured":"4 Whyte MP, Walkenhorst DA, Fedde KN, Henthorn PS, Hill CS. Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity. J Clin Endocrinol Metab. 1996;81(6):2142-8.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20230531094941_B5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0002-9343(57)90124-9","article-title":"Hypophosphatasia","volume":"22","author":"Fraser","year":"1957","unstructured":"5 Fraser D. Hypophosphatasia. Am J Med. 1957;22(5):730-46.","journal-title":"Am J Med"},{"issue":"5S2","key":"key20230531094941_B6","doi-asserted-by":"crossref","first-page":"5S51","DOI":"10.1016\/S0929-693X(18)30014-9","article-title":"Genetics of hypophosphatasia","volume":"24","author":"Mornet","year":"2017","unstructured":"6 Mornet E. Genetics of hypophosphatasia. Arch Pediatr. 2017;24(5S2):5S51-6.","journal-title":"Arch Pediatr"},{"issue":"3","key":"key20230531094941_B7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","article-title":"A molecular-based estimation of the prevalence of hypophosphatasia in the European population","volume":"75","author":"Mornet","year":"2011","unstructured":"7 Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B. A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet. 2011;75(3):439-45.","journal-title":"Ann Hum Genet"},{"issue":"3","key":"key20230531094941_B8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/archdischild-2013-305037","article-title":"Clinical and genetic aspects of hypophosphatasia in Japanese patients","volume":"99","author":"Taketani","year":"2014","unstructured":"8 Taketani T, Onigata K, Kobayashi H, Mushimoto Y, Fukuda S, Yamaguchi S. Clinical and genetic aspects of hypophosphatasia in Japanese patients. Arch Dis Child. 2014;99(3):211-5.","journal-title":"Arch Dis Child"},{"key":"key20230531094941_B9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","unstructured":"9 Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. 2015;75:229-39.","journal-title":"Bone"},{"issue":"6","key":"key20230531094941_B10","first-page":"2142","article-title":"Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity","volume":"81","author":"Whyte","year":"1996","unstructured":"10 Whyte MP, Walkenhorst DA, Fedde KN, Henthorn PS, Hill CS. Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity. J Clin Endocrinol Metab. 1996;81(6):2142-8.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20230531094941_B11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajmg.a.38531","article-title":"Discordant fetal phenotype of hypophosphatasia in two siblings","volume":"176","author":"Ikenoue","year":"2018","unstructured":"11 Ikenoue S, Miyakoshi K, Ishii T, Sato Y, Otani T, Akiba Y, et al. Discordant fetal phenotype of hypophosphatasia in two siblings. Am J Med Genet A. 2018;176(1):171-4.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"key20230531094941_B12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00431-008-0835-6","article-title":"Hypophosphatasia may lead to bone fragility: don't miss it","volume":"168","author":"Moulin","year":"2009","unstructured":"12 Moulin P, Vaysse F, Bieth E, Mornet E, Gennero I, Dalicieux-Laurencin S, et al. Hypophosphatasia may lead to bone fragility: don't miss it. Eur J Pediatr. 2009;168(7):783-8.","journal-title":"Eur J Pediatr"},{"issue":"10","key":"key20230531094941_B13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ejhg.2014.10","article-title":"Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia","volume":"22","author":"Hofmann","year":"2014","unstructured":"13 Hofmann C, Girschick H, Mornet E, Schneider D, Jakob F, Mentrup B. Unexpected high intrafamilial phenotypic variability observed in hypophosphatasia. Eur J Hum Genet. 2014;22(10):1160-4.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"key20230531094941_B14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia \u2013 Aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","unstructured":"14 Whyte MP. Hypophosphatasia \u2013 Aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233-46.","journal-title":"Nat Rev Endocrinol"},{"key":"key20230531094941_B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","article-title":"Hypophosphatasia: An overview for 2017","volume":"102","author":"Whyte","year":"2017","unstructured":"15 Whyte MP. Hypophosphatasia: An overview for 2017. Bone. 2017;102:15-25.","journal-title":"Bone"},{"issue":"1","key":"key20230531094941_B16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1272\/jnms.77.4","article-title":"The mechanism of mineralization and the role of alkaline phosphatase in health and disease","volume":"77","author":"Orimo","year":"2010","unstructured":"16 Orimo H. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch. 2010;77(1):4-12.","journal-title":"J Nippon Med Sch"},{"issue":"1","key":"key20230531094941_B17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bone.2013.01.024","article-title":"Clinical spectrum of hypophosphatasia diagnosed in adults","volume":"54","author":"Berkseth","year":"2013","unstructured":"17 Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA. Clinical spectrum of hypophosphatasia diagnosed in adults. Bone. 2013;54(1):21-7.","journal-title":"Bone"},{"issue":"5S2","key":"key20230531094941_B18","doi-asserted-by":"crossref","first-page":"5S93","DOI":"10.1016\/S0929-693X(18)30023-X","article-title":"Renal impairment in hypophosphatasia","volume":"24","author":"Bacchetta","year":"2017","unstructured":"18 Bacchetta J. Renal impairment in hypophosphatasia. Arch Pediatr. 2017;24(5S2):5S93-5.","journal-title":"Arch Pediatr"},{"issue":"23","key":"key20230531094941_B19","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.3390\/jcm10235676","article-title":"Hypophosphatasia","volume":"10","author":"Tournis","year":"2021","unstructured":"19 Tournis S, Yavropoulou MP, Polyzos SA, Doulgeraki A. Hypophosphatasia. J Clin Med. 2021;10(23):5676.","journal-title":"J Clin Med"},{"key":"key20230531094941_B20","doi-asserted-by":"crossref","first-page":"115300","DOI":"10.1016\/j.bone.2020.115300","article-title":"Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia","volume":"134","author":"Whyte","year":"2020","unstructured":"20 Whyte MP, Zhang F, Wenkert D, Mumm S, Berndt TJ, Kumar R. Hyperphosphatemia with low FGF7 and normal FGF23 and sFRP4 levels in the circulation characterizes pediatric hypophosphatasia. Bone. 2020;134:115300.","journal-title":"Bone"},{"issue":"2","key":"key20230531094941_B21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/cs0940203","article-title":"Relationship between serum alkaline phosphatase and pyridoxal-5\u2019-phosphate levels in hypophosphatasia","volume":"94","author":"Iqbal","year":"1998","unstructured":"21 Iqbal SJ, Brain A, Reynolds TM, Penny M, Holland S. Relationship between serum alkaline phosphatase and pyridoxal-5\u2019-phosphate levels in hypophosphatasia. Clin Sci (Lond). 1998;94(2):203-6.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"key20230531094941_B22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI112031","article-title":"Markedly increased circulating pyridoxal-5\u2019-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism","volume":"76","author":"Whyte","year":"1985","unstructured":"22 Whyte MP, Mahuren JD, Vrabel LA. Markedly increased circulating pyridoxal-5\u2019-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest. 1985;76(2):752-6.","journal-title":"J Clin Invest"},{"issue":"5S2","key":"key20230531094941_B23","doi-asserted-by":"crossref","first-page":"5S85","DOI":"10.1016\/S0929-693X(18)30021-6","article-title":"Neuromuscular features of hypophosphatasia","volume":"24","author":"Fonta","year":"2017","unstructured":"23 Fonta C, Salles JP. Neuromuscular features of hypophosphatasia. Arch Pediatr. 2017;24(5S2):5S85-8.","journal-title":"Arch Pediatr"},{"issue":"8","key":"key20230531094941_B24","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00198-020-05345-9","article-title":"Rare Bone Disease Action Group of the European Calcified Tissue Society. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment","volume":"31","author":"Bianchi","year":"2020","unstructured":"24 Bianchi ML, Bishop NJ, Gua\u00f1abens N, Hofmann C, Jakob F, Roux C, et al.; Rare Bone Disease Action Group of the European Calcified Tissue Society. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int. 2020;31(8):1445-60.","journal-title":"Osteoporos Int"},{"issue":"5S2","key":"key20230531094941_B25","doi-asserted-by":"crossref","first-page":"5S89","DOI":"10.1016\/S0929-693X(18)30022-8","article-title":"Craniosynostosis and hypophosphatasia","volume":"24","author":"Di Rocco","year":"2017","unstructured":"25 Di Rocco F, Baujat G, Cormier-Daire V, Rothenbuhler A, Linglart A. Craniosynostosis and hypophosphatasia. Arch Pediatr. 2017;24(5S2):5S89-92.","journal-title":"Arch Pediatr"},{"issue":"1","key":"key20230531094941_B26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13023-020-01500-x","article-title":"Pediatric hypophosphatasia: lessons learned from a retrospective single-center chart review of 50 children","volume":"15","author":"Vogt","year":"2020","unstructured":"26 Vogt M, Girschick H, Schweitzer T, Benoit C, Holl-Wieden A, Seefried L, et al. Pediatric hypophosphatasia: lessons learned from a retrospective single-center chart review of 50 children. Orphanet J Rare Dis. 2020;15(1):212.","journal-title":"Orphanet J Rare Dis"},{"issue":"5S2","key":"key20230531094941_B27","doi-asserted-by":"crossref","first-page":"5S74","DOI":"10.1016\/S0929-693X(18)30019-8","article-title":"Hypophosphatasia: the contribution of imaging","volume":"24","author":"Linglart","year":"2017","unstructured":"27 Linglart A, Salles JP. Hypophosphatasia: the contribution of imaging. Arch Pediatr. 2017;24(5S2):5S74-9.","journal-title":"Arch Pediatr"},{"issue":"8","key":"key20230531094941_B28","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00198-018-4552-3","article-title":"Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all","volume":"29","author":"Genest","year":"201","unstructured":"28 Genest F, Seefried L. Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all. Osteoporos Int. 201;29(8):1815-25.","journal-title":"Osteoporos Int"},{"issue":"4","key":"key20230531094941_B29","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2110","article-title":"Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters","volume":"29","author":"Gua\u00f1abens","year":"2014","unstructured":"29 Gua\u00f1abens N, Mumm S, M\u00f6ller I, Gonz\u00e1lez-Roca E, Peris P, Demertzis JL, et al. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters. J Bone Miner Res. 2014;29(4):929-34.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"key20230531094941_B30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","unstructured":"30 Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012;366(10):904-13.","journal-title":"N Engl J Med"},{"issue":"5S2","key":"key20230531094941_B31","doi-asserted-by":"crossref","first-page":"5S61","DOI":"10.1016\/S0929-693X(18)30016-2","article-title":"Perinatal and infantile hypophosphatasia: clinical features and treatment","volume":"24","author":"Baujat","year":"2017","unstructured":"31 Baujat G, Michot C, Le Quan Sang KH, Cormier-Daire V. Perinatal and infantile hypophosphatasia: clinical features and treatment. Arch Pediatr. 2017;24(5S2):5S61-5.","journal-title":"Arch Pediatr"},{"issue":"1","key":"key20230531094941_B32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14366\/usg.15008","article-title":"Prenatal diagnosis of hypophosphatasia congenita using ultrasonography","volume":"35","author":"Guguloth","year":"2016","unstructured":"32 Guguloth A, Aswani Y, Anandpara KM. Prenatal diagnosis of hypophosphatasia congenita using ultrasonography. Ultrasonography. 2016;35(1):83-6.","journal-title":"Ultrasonography"},{"issue":"5S2","key":"key20230531094941_B33","doi-asserted-by":"crossref","first-page":"5S66","DOI":"10.1016\/S0929-693X(18)30017-4","article-title":"Hypophosphatasia in children and adolescents: clinical features and treatment","volume":"24","author":"Rothenbuhler","year":"2017","unstructured":"33 Rothenbuhler A, Linglart A. Hypophosphatasia in children and adolescents: clinical features and treatment. Arch Pediatr. 2017;24(5S2):5S66-70.","journal-title":"Arch Pediatr"},{"issue":"2","key":"key20230531094941_B34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.11138\/ccmbm\/2017.14.1.230","article-title":"Hypophosphatasia: clinical manifestation and burden of disease in adult patients","volume":"14","author":"Conti","year":"2017","unstructured":"34 Conti F, Ciullini L, Pugliese G. Hypophosphatasia: clinical manifestation and burden of disease in adult patients. Clin Cases Miner Bone Metab. 2017;14(2):230-4.","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"7","key":"key20230531094941_B35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.48.7.571","article-title":"Crystal deposition in hypophosphatasia: a reappraisal","volume":"48","author":"Chuck","year":"1989","unstructured":"35 Chuck AJ, Pattrick MG, Hamilton E, Wilson R, Doherty M. Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis. 1989;48(7):571-6.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"key20230531094941_B36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00198-021-06145-5","article-title":"Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia","volume":"33","author":"Koga","year":"2022","unstructured":"36 Koga M, Kinoshita Y, Kato H, Kobayashi H, Shinoda Y, Nangaku M, et al. Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia. Osteoporos Int. 2022;33(2):505-9.","journal-title":"Osteoporos Int"},{"issue":"5S2","key":"key20230531094941_B37","doi-asserted-by":"crossref","first-page":"5S80","DOI":"10.1016\/S0929-693X(18)30020-4","article-title":"Hypophosphatasia: oral cavity and dental disorders","volume":"24","author":"Bloch-Zupan","year":"2017","unstructured":"37 Bloch-Zupan A, Vaysse F. Hypophosphatasia: oral cavity and dental disorders. Arch Pediatr. 2017;24(5S2):5S80-4.","journal-title":"Arch Pediatr"},{"issue":"4","key":"key20230531094941_B38","first-page":"309","volume":"11","author":"Sobel","year":"1953","unstructured":"38 Sobel EH, Clark LC, Fox, RP. Rickets, deficiency of alkaline phosphatase activity and premature loss of teeth in childhood. 1953;11(4):309-22.","journal-title":"Rickets, deficiency of alkaline phosphatase activity and premature loss of teeth in childhood"},{"key":"key20230531094941_B39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bone.2018.01.022","article-title":"Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology","volume":"110","author":"Whyte","year":"2018","unstructured":"39 Whyte MP, Coburn SP, Ryan LM, Ericson KL, Zhang F. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology. Bone. 2018;110:96-106.","journal-title":"Bone"},{"issue":"3","key":"key20230531094941_B40","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00198-015-3346-0","article-title":"Absence of recognition of low alkaline phosphatase level in a tertiary care hospital","volume":"27","author":"Maman","year":"2016","unstructured":"40 Maman E, Borderie D, Roux C, Briot K. Absence of recognition of low alkaline phosphatase level in a tertiary care hospital. Osteoporos Int. 2016;27(3):1251-4.","journal-title":"Osteoporos Int"},{"key":"key20230531094941_B41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpeds.2016.01.045","article-title":"A diagnostic algorithm for children with low alkaline phosphatase activities: lessons learned from laboratory screening for hypophosphatasia","volume":"172","author":"Saraff","year":"2016","unstructured":"41 Saraff V, Narayanan VK, Lawson AJ, Shaw NJ, Preece MA, H\u00f6gler W. A diagnostic algorithm for children with low alkaline phosphatase activities: lessons learned from laboratory screening for hypophosphatasia. J Pediatr. 2016;172:181-6.","journal-title":"J Pediatr"},{"issue":"5S2","key":"key20230531094941_B42","doi-asserted-by":"crossref","first-page":"5S57","DOI":"10.1016\/S0929-693X(18)30015-0","article-title":"Laboratory diagnosis of hypophosphatasia","volume":"24","author":"Gennero","year":"2017","unstructured":"42 Gennero I, Conte-Auriol F, Salles JP. Laboratory diagnosis of hypophosphatasia. Arch Pediatr. 2017;24(5S2):5S57-60.","journal-title":"Arch Pediatr"},{"issue":"4","key":"key20230531094941_B43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jbmr.3075","article-title":"Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges","volume":"32","author":"Whyte","year":"2017","unstructured":"43 Whyte MP. Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges. J Bone Miner Res. 2017;32(4):667-75.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"key20230531094941_B44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41431-020-00732-6","article-title":"Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation","volume":"29","author":"Mornet","year":"2021","unstructured":"44 Mornet E, Taillandier A, Domingues C, Dufour A, Benaloun E, Lavaud N, et al. Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet. 2021;29(2):289-99.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"key20230531094941_B45","first-page":"623","article-title":"A two-year follow-up of asfotase alfa replacement in a patient with hypophosphatasia: clinical, biochemical, and radiological evaluation","volume":"64","author":"Reis","year":"2021","unstructured":"45 Reis FS, Gomes DC, Arantes HP, Lazaretti-Castro M. A two-year follow-up of asfotase alfa replacement in a patient with hypophosphatasia: clinical, biochemical, and radiological evaluation. Arch Endocrinol Metab. 2021;64(5):623-9.","journal-title":"Arch Endocrinol Metab"},{"issue":"10","key":"key20230531094941_B46","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00198-011-1528-y","article-title":"Skeletal mineralization defects in adult hypophosphatasia\u2013\u2013a clinical and histological analysis","volume":"22","author":"Barvencik","year":"2011","unstructured":"46 Barvencik F, Beil FT, Gebauer M, Busse B, Koehne T, Seitz S, et al. Skeletal mineralization defects in adult hypophosphatasia\u2013\u2013a clinical and histological analysis. Osteoporos Int. 2011;22(10):2667-75.","journal-title":"Osteoporos Int"},{"key":"key20230531094941_B47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1876525400901010008","article-title":"Hypophosphatasia \u2013 recent advances in diagnosis and treatment","volume":"1","author":"Beck","year":"2009","unstructured":"47 Beck C, Morbach H, Stenzel M, Collmann H, Schneider P, Girschick HJ. Hypophosphatasia \u2013 recent advances in diagnosis and treatment. Open Bone J. 2009,1:8-15.","journal-title":"Open Bone J"},{"issue":"3","key":"key20230531094941_B48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11914-016-0309-0","article-title":"Hypophosphatasia","volume":"14","author":"Linglart","year":"2016","unstructured":"48 Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016;14(3):95-105.","journal-title":"Curr Osteoporos Rep"},{"issue":"5","key":"key20230531094941_B49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jbmr.1565","article-title":"\u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia","volume":"27","author":"Sutton","year":"2012","unstructured":"49 Sutton RA, Mumm S, Coburn SP, Ericson KL, Whyte MP. \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res. 2012;27(5):987-94.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"key20230531094941_B50","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1359\/jbmr.081253","article-title":"Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia","volume":"24","author":"Whyte","year":"2009","unstructured":"50 Whyte MP. Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res. 2009;24(6):1132-4.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"key20230531094941_B51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85971","article-title":"Asfotase alfa therapy for children with hypophosphatasia","volume":"1","author":"Whyte","year":"2016","unstructured":"51 Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, et al. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 2016;1(9):e85971.","journal-title":"JCI Insight"},{"issue":"2","key":"key20230531094941_B52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","article-title":"Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial","volume":"7","author":"Whyte","year":"2019","unstructured":"52 Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, et al. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019;7(2):93-105.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"key20230531094941_B53","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jc.2015-3462","article-title":"Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia","volume":"101","author":"Whyte","year":"2016","unstructured":"53 Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, et al. Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endocrinol Metab. 2016;101(1):334-42.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20230531094941_B54","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/archdischild-2015-309579","article-title":"Transformative therapy in hypophosphatasia","volume":"101","author":"Bishop","year":"2016","unstructured":"54 Bishop N, Munns CF, Ozono K. Transformative therapy in hypophosphatasia. Arch Dis Child. 2016;101(6):514-5.","journal-title":"Arch Dis Child"},{"issue":"2","key":"key20230531094941_B55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00198-017-4267-x","article-title":"Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia","volume":"29","author":"Bowden","year":"2018","unstructured":"55 Bowden SA, Adler BH. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia. Osteoporos Int. 2018;29(2):511-5.","journal-title":"Osteoporos Int"},{"issue":"9","key":"key20230531094941_B56","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00198-018-4613-7","article-title":"Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia","volume":"29","author":"Bowden","year":"2018","unstructured":"56 Bowden SA, Adler BH. Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia. Osteoporos Int. 2018;29(9):2155-6.","journal-title":"Osteoporos Int"},{"issue":"9","key":"key20230531094941_B57","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10395","article-title":"Physical Function and Health-Related Quality of Life in Adults Treated With Asfotase Alfa for Pediatric-Onset Hypophosphatasia","volume":"4","author":"Genest","year":"2020","unstructured":"57 Genest F, Rak D, Petryk A, Seefried L. Physical Function and Health-Related Quality of Life in Adults Treated With Asfotase Alfa for Pediatric-Onset Hypophosphatasia. JBMR Plus. 2020;4(9):e10395.","journal-title":"JBMR Plus"},{"key":"key20230531094941_B58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","unstructured":"58 Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, et al. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone. 2019;121:149-62.","journal-title":"Bone"},{"issue":"6","key":"key20230531094941_B59","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.4158\/ACCR-2019-0143","article-title":"Adult-onset hypophosphatasia: before and after treatment with asfotase alfa","volume":"5","author":"Magdaleno","year":"2019","unstructured":"59 Magdaleno AL, Singh S, Venkataraman S, Perilli GA, Lee YY. Adult-onset hypophosphatasia: before and after treatment with asfotase alfa. AACE Clin Case Rep. 2019;5(6):e344-8.","journal-title":"AACE Clin Case Rep"},{"key":"key20230531094941_B60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymgmr.2017.10.006","article-title":"Enzyme replacement therapy in perinatal hypophosphatasia: case report of a negative outcome and lessons for clinical practice","volume":"14","author":"Costain","year":"2017","unstructured":"60 Costain G, Moore AM, Munroe L, Williams A, Zlotnik Shaul R, Rockman-Greenberg C, et al. Enzyme replacement therapy in perinatal hypophosphatasia: case report of a negative outcome and lessons for clinical practice. Mol Genet Metab Rep. 2017;14:22-6.","journal-title":"Mol Genet Metab Rep"},{"issue":"1-2","key":"key20230531094941_B61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2017.07.010","article-title":"Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa","volume":"122","author":"Kishnani","year":"2017","unstructured":"61 Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, et al. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017;122(1-2):4-17.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"key20230531094941_B62","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00198-021-06025-y","article-title":"Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa","volume":"32","author":"Seefried","year":"2021","unstructured":"62 Seefried L, Rak D, Petryk A, Genest F. Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa. Osteoporos Int. 2021;32(12):2505-13.","journal-title":"Osteoporos Int"},{"key":"key20230531094941_B63","doi-asserted-by":"crossref","first-page":"115695","DOI":"10.1016\/j.bone.2020.115695","article-title":"Characterization of physical, functional, and cognitive performance in 15 adults with hypophosphatasia","volume":"142","author":"Durrough","year":"2021","unstructured":"63 Durrough C, Colazo JM, Simmons J, Hu JR, Hudson M, Black M, et al. Characterization of physical, functional, and cognitive performance in 15 adults with hypophosphatasia. Bone. 2021;142:115695.","journal-title":"Bone"},{"issue":"11","key":"key20230531094941_B64","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/jbmr.4130","article-title":"Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry","volume":"35","author":"Seefried","year":"2020","unstructured":"64 Seefried L, Dahir K, Petryk A, H\u00f6gler W, Linglart A, Martos-Moreno G\u00c1, et al. Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry. J Bone Miner Res. 2020;35(11):2171-8.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"key20230531094941_B65","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10223","article-title":"Bisphosphonate Use and Fractures in Adults with Hypophosphatasia","volume":"3","author":"Rassie","year":"2019","unstructured":"65 Rassie K, Dray M, Michigami T, Cundy T. Bisphosphonate Use and Fractures in Adults with Hypophosphatasia. JBMR Plus. 2019;3(10):e10223.","journal-title":"JBMR Plus"},{"key":"key20230531094941_B66","doi-asserted-by":"crossref","first-page":"115795","DOI":"10.1016\/j.bone.2020.115795","article-title":"Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic","volume":"144","author":"Desborough","year":"2021","unstructured":"66 Desborough R, Nicklin P, Gossiel F, Balasubramanian M, Walsh JS, Petryk A, et al. Clinical and biochemical characteristics of adults with hypophosphatasia attending a metabolic bone clinic. Bone. 2021;144:115795.","journal-title":"Bone"},{"issue":"9","key":"key20230531094941_B67","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","article-title":"Clinical, radiographic and biochemical characteristics of adult hypophosphatasia","volume":"28","author":"Schmidt","year":"2017","unstructured":"67 Schmidt T, Mussawy H, Rolvien T, Hawellek T, Hubert J, R\u00fcther W, et al. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int. 2017;28(9):2653-62.","journal-title":"Osteoporos Int"},{"issue":"2","key":"key20230531094941_B68","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4158\/EP.14.2.204","article-title":"Treatment of adult hypophosphatasia with teriparatide","volume":"14","author":"Camacho","year":"2008","unstructured":"68 Camacho PM, Painter S, Kadanoff R. Treatment of adult hypophosphatasia with teriparatide. Endocr Pract. 2008;14(2): 204-8.","journal-title":"Endocr Pract"},{"issue":"8","key":"key20230531094941_B69","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10215","article-title":"Outcome of teriparatide treatment on fracture healing complications and symptomatic bone marrow edema in four adult patients with hypophosphatasia","volume":"3","author":"Schmidt","year":"2019","unstructured":"69 Schmidt T, Rolvien T, Linke C, Jandl NM, Oheim R, Amling M, et al. Outcome of teriparatide treatment on fracture healing complications and symptomatic bone marrow edema in four adult patients with hypophosphatasia. JBMR Plus. 2019;3(8):e10215.","journal-title":"JBMR Plus"},{"issue":"8","key":"key20230531094941_B70","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4158\/EP15890.OR","article-title":"Adult hypophosphatasia treated with teriparatide: report of 2 patients and review of the literature","volume":"22","author":"Camacho","year":"2016","unstructured":"70 Camacho PM, Mazhari AM, Wilczynski C, Kadanoff R, Mumm S, Whyte MP. Adult hypophosphatasia treated with teriparatide: report of 2 patients and review of the literature. Endocr Pract. 2016;22(8):941-50.","journal-title":"Endocr Pract"},{"issue":"4","key":"key20230531094941_B71","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/jc.2006-1902","article-title":"Adult hypophosphatasia treated with teriparatide","volume":"92","author":"Whyte","year":"2007","unstructured":"71 Whyte MP, Mumm S, Deal C. Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab. 2007;92(4):1203-8.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20230531094941_B72","first-page":"584","article-title":"Adult hypophosphatasia treated with reduced frequency of teriparatide dosing","volume":"21","author":"Polyzos","year":"2021","unstructured":"72 Polyzos SA, Tournis S, Goulas A, Kollia P, Whyte MP. Adult hypophosphatasia treated with reduced frequency of teriparatide dosing. J Musculoskelet Neuronal Interact. 2021;21(4):584-9.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"3","key":"key20230531094941_B73","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00223-011-9562-5","article-title":"Failure of teriparatide in treatment of bone complications of adult hypophosphatasia","volume":"90","author":"Laroche","year":"2012","unstructured":"73 Laroche M. Failure of teriparatide in treatment of bone complications of adult hypophosphatasia. Calcif Tissue Int. 2012;90(3):250.","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"key20230531094941_B74","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/jc.2009-1965","article-title":"Lack of sustained response to teriparatide in a patient with adult hypophosphatasia","volume":"95","author":"Gagnon","year":"2010","unstructured":"74 Gagnon C, Sims NA, Mumm S, McAuley SA, Jung C, Poulton IJ, et al. Lack of sustained response to teriparatide in a patient with adult hypophosphatasia. J Clin Endocrinol Metab. 2010;95(3):1007-12.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20230531094941_B75","article-title":"A Bone histomorphometric analysis of hypophosphatasia-related osteoporosis after teriparatide treatment","author":"Mizuno","year":"2022","unstructured":"75 Mizuno H, Sawa N, Sekine A, Inoue N, Oba Y, Ikuma D, et al. A Bone histomorphometric analysis of hypophosphatasia-related osteoporosis after teriparatide treatment. Intern Med. 2022.","journal-title":"Intern Med"},{"issue":"12","key":"key20230531094941_B76","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1210\/jc.2010-1168","article-title":"Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia","volume":"95","author":"Schalin-J\u00e4ntti","year":"2010","unstructured":"76 Schalin-J\u00e4ntti C, Mornet E, Lamminen A, V\u00e4lim\u00e4ki MJ. Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. J Clin Endocrinol Metab. 2010;95(12):5174-9.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20230531094941_B77","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1172\/JCI83731","article-title":"Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia","volume":"127","author":"Seefried","year":"2017","unstructured":"77 Seefried L, Baumann J, Hemsley S, Hofmann C, Kunstmann E, Kiese B, et al. Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia. J Clin Invest. 2017;127(6):2148-58.","journal-title":"J Clin Invest"},{"issue":"3","key":"key20230531094941_B78","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jbspin.2017.12.001","article-title":"Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures","volume":"85","author":"Righetti","year":"2018","unstructured":"78 Righetti M, Wach J, Desmarchelier R, Coury F. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures. Joint Bone Spine. 2018;85(3):365-7.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"key20230531094941_B79","first-page":"266","article-title":"Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report","volume":"6","author":"Doshi","year":"2009","unstructured":"79 Doshi KB, Hamrahian AH, Licata AA. Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report. Clin Cases Miner Bone Metab. 2009;6(3):266-9.","journal-title":"Clin Cases Miner Bone Metab"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T13:50:33Z","timestamp":1685541033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/hypophosphatasia-from-birth-to-adulthood\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,30]]}},"alternative-id":["10.20945\/2359-3997000000626"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000626","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e000626"}}